TLDR Markets rallied November 20, 2025 with Nasdaq up 2%, Dow up 600 points following Nvidia earnings Salesforce at $229 trades 50% below fair value with analyst target of $323. 51 showing 41% upside Merck near $95 undervalued by 50% with Keytruda drug driving pharmaceutical revenue PayPal in mid-$70s faces fintech competition but analysts see room for growth Adobe and Comcast trade below fair value with price targets suggesting 34-36% gains The stock market posted strong gains on November 20, 2025. Nvidia’s earnings results drove the Nasdaq Composite up over 2%. The Dow Jones Industrial Average climbed more than 600 points during the session. The S&P 500 advanced 1. 5% on the day. Employment data exceeded forecasts and boosted investor sentiment. Speculation about Federal Reserve rate cuts is growing. Five S&P 500 companies are trading well below analyst estimates of fair value. Wall Street price targets indicate potential gains ranging from 10% to 41%. These stocks span multiple sectors including technology, healthcare, payments, and media. Salesforce (CRM) Salesforce shares trade around $229, approximately 50% under estimated fair value. The cloud-based software company provides customer relationship management tools through its Customer 360 platform. Businesses use these services for digital transformation projects. Salesforce, Inc., CRM The company is integrating artificial intelligence features into its products. Enterprise demand for AI-powered CRM solutions continues to grow. Salesforce maintains a leadership position in the cloud software market. Analysts assign a Moderate Buy consensus from 39 ratings. The breakdown includes 25 Buy ratings, 13 Hold ratings, and 1 Sell rating. The average price target sits at $323. 51. This target implies 41% upside potential from current levels. Two analysts downgraded the stock over the past 90 days. Competition in the software-as-a-service space is intensifying. Merck (MRK) Merck stock trades near $95, undervalued by roughly 50% according to analysts. The pharmaceutical company generates billions from Keytruda, its blockbuster oncology drug. Cancer treatment remains a high-growth area in healthcare. Salesforce, Inc., CRM The company maintains a diverse product pipeline beyond oncology. Vaccines and animal health products provide revenue diversification. Merck targets aging populations in developed markets. Analyst sentiment leans toward Hold based on 18 ratings. The split shows 2 Strong Buy, 5 Buy, 10 Hold, and 1 Sell. The average price target stands at $104. 88. This represents modest 10% upside potential. One upgrade and one downgrade occurred in the last three months. Analysts weigh patent cliff risks against pipeline innovation. PayPal (PYPL) PayPal processes digital payments with shares trading in the mid-$70s range. The company operates below fair value estimates despite growing e-commerce volume. Online transactions continue increasing across retail categories. PayPal Holdings, Inc., PYPL The fintech sector faces mounting competition from newer platforms. PayPal benefits from an established merchant network and consumer base. Partnerships with retailers support transaction volume growth. The consensus from 37 analysts is Hold overall. Ratings include 15 Buy, 18 Hold, and 4 Sell opinions. The average target price stands at $82. 56. High-end estimates reach $107 per share. The rating has weakened from Moderate Buy earlier this year. DBS Bank recently cut its target to $70 while Truist raised its forecast to $66 in November 2025. Adobe (ADBE) Adobe shares hover near $318, undervalued by about 39% based on analyst models. Creative Cloud dominates the digital content creation market for professionals. Photoshop and Premiere Pro remain industry standard tools. The company launched Firefly, an AI-powered creative tool. This technology is attracting new users to the Adobe ecosystem. Subscription revenue provides predictable cash flow. Analysts rate the stock Hold overall from 29 opinions. The breakdown shows 1 Strong Buy, 13 Buy, 12 Hold, and 3 Sell. The average target price is $433. 41. This suggests 36% potential upside from current prices. Two downgrades appeared in the past quarter. Tech sector valuations remain a concern for some analysts. Comcast (CMCSA) Comcast trades around $27 per share, down 62% from fair value estimates. The company provides broadband internet to millions of subscribers. NBCUniversal creates content for television and streaming platforms. Peacock streaming service is gaining subscribers and reducing cord-cutting impact. Broadband revenue remains stable as internet demand stays strong. The media division includes theme parks and film studios. The consensus rating is Hold from 34 analysts. This includes 11 Buy, 21 Hold, and 2 Sell ratings. The average price target sits at $35. 92. This represents 34% upside potential from current levels. Four downgrades and two upgrades occurred over the past 90 days. Streaming competition creates uncertainty in media sector forecasts. The post Best Undervalued Stocks to Buy Today, According to Grok appeared first on Blockonomi.
https://bitcoinethereumnews.com/tech/best-undervalued-stocks-to-buy-today-according-to-grok/
